Travere Therapeutics
TVTX
TVTX
130 hedge funds and large institutions have $516M invested in Travere Therapeutics in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+8
Holders Change %
+6.56%
% of All Funds
2.86%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
25
Increased
54
Reduced
32
Closed
17
Calls
$6.19M
Puts
$8.72M
Net Calls
-$2.54M
Net Calls Change
+$36.9M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$46.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.54M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.2M |
| 4 |
Renaissance Technologies
New York
|
+$4.81M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$2.95M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$17.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$12.3M |
| 3 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$12.3M |
| 4 |
SCM
Scopia Capital Management
New York
|
-$7.71M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.99M |
